News

News | December 18, 2018

Palvella Therapeutics Announces $10 Million in Funding from Ligand Pharmaceuticals to Accelerate PTX-022 through Phase 2/3 Clinical Study in Pachyonychia Congenita

Press Release | December 18, 2018

Entrada Therapeutics Raises $59 Million Series A to Advance Intracellular Biologics Platform

Press Release | December 13, 2018

Orchard Therapeutics Announces the Build-out of New Gene Therapy Manufacturing Facility in California

Press Release | December 6, 2018

Precision BioSciences and Durham STEM Students Lead Launch of First Genome Editing Experiment Into Space

News | November 27, 2018

Precision BioSciences Receives FDA Authorization to Initiate Clinical Study of Gene Edited Cancer Immunotherapy

News | November 20, 2018

Pliant Therapeutics Receives FDA Orphan Drug Designation for Lead Program PLN-74809 in Primary Sclerosing Cholangitis

News | November 5, 2018

Orchard Therapeutics Announces Closing of $225 Million Initial Public Offering

Press Release | July 16, 2018

Pliant Therapeutics Raises $62 Million in Series B Financing

Press Release | July 16, 2018

Verge Genomics Announces $32 Million Series A

News | June 27, 2018

Carisma Nabs $53 Million Series A for Cellular Cancer Therapy

Press Release | June 26, 2018

Skyhawk Therapeutics Announces $40 Million Equity Investment Round

News | June 26, 2018

Kauffman Fellows Celebrates Its Most Diverse Group of Talented Leaders With Class 23

News | June 26, 2018

Genome Editing Startup Precision BioSciences Scores $110 Million Series B

Press Release | June 26, 2018

Precision BioSciences Raises $110M

News | June 26, 2018

Skyhawk Therapeutics Gains $100 Million Through Venture Round, Collaboration

News | June 26, 2018

CAR Macrophage Tumor Tech Created by UPenn Star Scientists Gets $53M

Press Release | June 20, 2018

Aptinyx Announces Pricing of Initial Public Offering

News | April 12, 2018

UK Gene Therapy Firm Orchard Plans Stock Offer After GSK Deal